rs1536365

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_014363.6(SACS):​c.1656A>G​(p.Leu552Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 1,614,152 control chromosomes in the GnomAD database, including 11,253 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L552L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.088 ( 784 hom., cov: 33)
Exomes 𝑓: 0.12 ( 10469 hom. )

Consequence

SACS
NM_014363.6 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.212

Publications

15 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women's Health, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_014363.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.03).
BP6
Variant 13-23354956-T-C is Benign according to our data. Variant chr13-23354956-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130202.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.212 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.1656A>Gp.Leu552Leu
synonymous
Exon 8 of 10NP_055178.3
SACS
NM_001437336.1
c.1656A>Gp.Leu552Leu
synonymous
Exon 8 of 11NP_001424265.1A0A804HIQ1
SACS
NM_001278055.2
c.1215A>Gp.Leu405Leu
synonymous
Exon 6 of 8NP_001264984.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.1656A>Gp.Leu552Leu
synonymous
Exon 8 of 10ENSP00000371729.3Q9NZJ4-1
SACS
ENST00000455470.6
TSL:1
c.1656A>Gp.Leu552Leu
synonymous
Exon 8 of 11ENSP00000406565.2H0Y6M8
SACS
ENST00000402364.1
TSL:2
c.-595A>G
5_prime_UTR_premature_start_codon_gain
Exon 6 of 8ENSP00000385844.1Q9NZJ4-2

Frequencies

GnomAD3 genomes
AF:
0.0886
AC:
13478
AN:
152192
Hom.:
783
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0202
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.0786
Gnomad ASJ
AF:
0.0822
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.128
Gnomad FIN
AF:
0.155
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.117
Gnomad OTH
AF:
0.0957
GnomAD2 exomes
AF:
0.112
AC:
28125
AN:
251274
AF XY:
0.116
show subpopulations
Gnomad AFR exome
AF:
0.0177
Gnomad AMR exome
AF:
0.0826
Gnomad ASJ exome
AF:
0.0807
Gnomad EAS exome
AF:
0.115
Gnomad FIN exome
AF:
0.158
Gnomad NFE exome
AF:
0.122
Gnomad OTH exome
AF:
0.115
GnomAD4 exome
AF:
0.116
AC:
169589
AN:
1461842
Hom.:
10469
Cov.:
34
AF XY:
0.117
AC XY:
85027
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.0174
AC:
583
AN:
33480
American (AMR)
AF:
0.0814
AC:
3640
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0806
AC:
2107
AN:
26134
East Asian (EAS)
AF:
0.135
AC:
5344
AN:
39700
South Asian (SAS)
AF:
0.130
AC:
11253
AN:
86258
European-Finnish (FIN)
AF:
0.163
AC:
8682
AN:
53400
Middle Eastern (MID)
AF:
0.102
AC:
591
AN:
5768
European-Non Finnish (NFE)
AF:
0.118
AC:
130716
AN:
1111984
Other (OTH)
AF:
0.110
AC:
6673
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
9973
19946
29920
39893
49866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4654
9308
13962
18616
23270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0885
AC:
13479
AN:
152310
Hom.:
784
Cov.:
33
AF XY:
0.0902
AC XY:
6721
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0201
AC:
836
AN:
41572
American (AMR)
AF:
0.0785
AC:
1201
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0822
AC:
285
AN:
3466
East Asian (EAS)
AF:
0.127
AC:
661
AN:
5186
South Asian (SAS)
AF:
0.130
AC:
626
AN:
4828
European-Finnish (FIN)
AF:
0.155
AC:
1647
AN:
10616
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.117
AC:
7992
AN:
68024
Other (OTH)
AF:
0.0942
AC:
199
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
634
1268
1901
2535
3169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.104
Hom.:
1697
Bravo
AF:
0.0796
Asia WGS
AF:
0.113
AC:
392
AN:
3478
EpiCase
AF:
0.112
EpiControl
AF:
0.113

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Charlevoix-Saguenay spastic ataxia (5)
-
-
3
not provided (3)
-
-
3
not specified (3)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
8.0
DANN
Benign
0.55
PhyloP100
-0.21
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=283/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1536365;
hg19: chr13-23929095;
COSMIC: COSV66536720;
COSMIC: COSV66536720;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.